<DOC>
	<DOCNO>NCT01149577</DOCNO>
	<brief_summary>Acute sub-chronic administration olanzapine show favourable effect sleep disturbances previously medicate schizophrenia patient predominantly negative symptom . The present study carry clarify effect olanzapine polysomnographic profile schizophrenia patient acute phase illness control drug effect .</brief_summary>
	<brief_title>Effect Olanzapine Sleep Electroencephalogram ( EEG ) Schizophrenia Patients</brief_title>
	<detailed_description>Twenty schizophrenia patient ( 11 drug naïve 9 drug free ) study period six week olanzapine treatment . Patients assessed baseline BPRS , PANSS , CDSS UKU side effect rating scale baseline 40 channel polysomnography do . After initial assessment , patient put olanzapine treatment , flexible dosage base clinical response , period six week final assessment clinical rating scale polysomnography do . The sleep data score manually stag base Rechtschaffen Kales criterion .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . Male patient fulfil International Classification Diseases10 Diagnostic Criteria Research schizophrenia 2 . Aged 1850 Yrs 3 . Drug naïve drug free ( receive psychotropic medication past 4 month ) 4 . Consenting 1 . Any comorbid psychiatric illness 2 . Significant medical neurological illness 3 . History significant head injury , epilepsy 4 . Substance use past 4 month exclude nicotine caffeine 5 . Presence primary sleep disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Olanzapine</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Polysomnography</keyword>
	<keyword>Slow wave sleep</keyword>
</DOC>